Japan Tobacco Inc - Company Profile
Powered by 
All the sales intelligence you need on Japan Tobacco Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Japan Tobacco Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Japan Tobacco Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Japan Tobacco Inc (JT Group) is a tobacco company. Its primary activities include the manufacture and sale of tobacco products and production of processed foods. The company's major products comprise a wide range of tobacco brands, frozen noodles, prescription drugs, packaged cooked rice, seasonings, and frozen and ambient processed foods. JT Group’s major brands include Winston, Camel, LD, and Mevius in the tobacco sector. It has a presence in Japan, France, Germany, Italy, the Philippines, Taiwan, Jordan, Kazakhstan, and Romania. JT Group is headquartered in Minato-ku, Tokyo, Japan.
Headquarters
Japan
Address
Kamiyacho Trust Tower, 4-1-1, Toranomon, Minato-Ku, Tokyo, 105-6927
Website
www.jti.co.jp
Telephone
81 3 66362914
No of Employees
52,867
Industry
Consumer Packaged Goods
Ticker Symbol & Exchange
2914 (TYO)
Revenue (2024)
$22.3B
10.1%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
184.6%
(2024 vs 2023)
Market Cap*
$89.6B
Net Profit Margin (2024)
XYZ
158.5%
(2024 vs 2023)
* As of and is in US$
Japan Tobacco Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| - | - | - |
| Cigarettes | Distribution Services | Mevius |
| Tobacco | Marketing and Promotional Services | Winston |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In July, the company entered into an agreement to acquire the BREAK and Moro brands from Scandinavian Tobacco Group A/S. |
| 2026 | New Products/Services | In May, D-LAB and Leave a Nest launch the Second Cohort of D-0., an Incubation Platform to Co-Creating fulfilling future society. |
| 2025 | Divestiture | In December, the company sold Akros Pharma to Shionogi Inc. |
Competitor Comparison
| Key Parameters | Japan Tobacco Inc | Imperial Brands Plc | Philip Morris International Inc | British American Tobacco Plc | Altria Group Inc |
|---|---|---|---|---|---|
| Headquarters | Japan | United Kingdom | United States of America | United Kingdom | United States of America |
| City | Minato-Ku | Bristol | Stamford | London | Richmond |
| State/Province | Tokyo | England | Connecticut | England | Virginia |
| No. of Employees | 52,867 | 25,100 | 84,900 | 50,290 | 5,900 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mutsuo Iwai | Chairman | Executive Board | 2020 | 66 |
| Masamichi Terabatake | Director; Chief Executive Officer; President | Executive Board | 2018 | 61 |
| Shigeaki Okamoto | Deputy Chairman | Executive Board | 2022 | 65 |
| Koji Shimayoshi | Director; Executive Vice President - Corporate Governance, Compliance, Corporate Strategy, Sustainability, People & Culture, Information Technology, Legal, Operation Review and Business Assurance, Pharmaceutical Business and Food Business | Executive Board | 2024 | 58 |
| Kei Nakano | Executive Vice President; Director | Executive Board | 2023 | 58 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer